Clinical trial
Efficacy and Safety of Valsartan/Amlodipine Compared to Amlodipine in Patients…
NCT00437645 · Novartis Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00437645 |
|---|---|
| Title | Efficacy and Safety of Valsartan/Amlodipine Compared to Amlodipine in Patients With Essential Hypertension |
| Official title | A Double-blind, Randomized, Multicenter, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of Treatment With the Combination of Valsartan/Amlodipine 160/5 mg Compared to Amlodipine 10 mg in Patients With Essential Hypertension Not Adequately Controlled With Amlodipine 5 mg… |
| Lead sponsor | Novartis Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Essential Hypertension |
| Intervention type | Drug |
| Interventions | Valsartan 160 mg capsules, Amlodipine 5 mg capsules, placebo |
| Enrollment | 1,183 |
| Start date | Jan 1, 2007 |
| Primary completion | Nov 1, 2007 |
| Completion | Nov 1, 2007 |
| First posted | Feb 21, 2007 |
| Last update posted | Nov 11, 2014 |
| Countries | Argentina, Chile, Ecuador, Finland, France, Germany, Italy, Norway, Spain, Sweden, Switzerland, Turkey (Türkiye) |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: